Hay JE - Search Results

1

Use of fatty donor liver is associated with diminished early patient and graft survival.

Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, Gores GJ, Krom RA. Marsman WA, et al. Among authors: hay je. Transplantation. 1996 Nov 15;62(9):1246-51. doi: 10.1097/00007890-199611150-00011. Transplantation. 1996. PMID: 8932265

2

Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.

Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, Wahlstrom HE, Krom RA. Wiesner RH, et al. Among authors: hay je. Hepatology. 1992 Nov;16(5):1290-9. Hepatology. 1992. PMID: 1427667 Review.

3

Bone disease in liver transplant recipients: incidence, timing, and risk factors.

Porayko MK, Wiesner RH, Hay JE, Krom RA, Dickson ER, Beaver S, Schwerman L. Porayko MK, et al. Among authors: hay je. Transplant Proc. 1991 Feb;23(1 Pt 2):1462-5. Transplant Proc. 1991. PMID: 1989266 No abstract available.

4

Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma.

Tan CK, Gores GJ, Steers JL, Porayko MK, Hay JE, Rakela J, Wiesner RH, Krom RA. Tan CK, et al. Among authors: hay je. Mayo Clin Proc. 1994 Jun;69(6):509-14. doi: 10.1016/s0025-6196(12)62240-x. Mayo Clin Proc. 1994. PMID: 7514702

5

Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue.

Sandborn WJ, Lawson GM, Cody TJ, Porayko MK, Hay JE, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: hay je. Hepatology. 1995 Jan;21(1):70-6. Hepatology. 1995. PMID: 7528712 Clinical Trial.

6

Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.

Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Wahlstrom HE, Sanchez-Urdazpal L, Richards T, Crotty P, Beaver S, et al. Porayko MK, et al. Among authors: hay je. Transplant Proc. 1993 Feb;25(1 Pt 1):665-8. Transplant Proc. 1993. PMID: 7679835 Clinical Trial. No abstract available.

7

Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.

Wiesner RH, Porayko MK, Wahlstrom HE, Gores GJ, Kamath PS, Hay JE, Krom RA. Wiesner RH, et al. Among authors: hay je. Transplant Proc. 1993 Apr;25(2):1791-3. Transplant Proc. 1993. PMID: 7682352 Clinical Trial. No abstract available.

8

Treatment of early cellular rejection following liver transplantation with intravenous methylprednisolone. The effect of dose on response.

Wiesner RH, Ludwig J, Krom RA, Steers JL, Porayko MK, Gores GJ, Hay JE. Wiesner RH, et al. Among authors: hay je. Transplantation. 1994 Nov 15;58(9):1053-6. doi: 10.1097/00007890-199411150-00015. Transplantation. 1994. PMID: 7974734 No abstract available.

9

Etiology and incidence of unconjugated hyperbilirubinemia after orthotopic liver transplantation.

Gates LK Jr, Wiesner RH, Krom RA, Steers J, Gores GJ, Hay JE, Porayko MK. Gates LK Jr, et al. Among authors: hay je. Am J Gastroenterol. 1994 Sep;89(9):1541-3. Am J Gastroenterol. 1994. PMID: 8079934

10

Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.

Park KM, Hay JE, Lee SG, Lee YJ, Wiesner RH, Porayko MK, Krom RA. Park KM, et al. Among authors: hay je. Transplant Proc. 1996 Jun;28(3):1738-40. Transplant Proc. 1996. PMID: 8658863 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters